Orexo Annual Report 2016
Orexo Acquires Exclusive US Rights to Commercialize deprexis - IndiaMedToday
First profitable year in the history of Orexo AB
Orexo — The opioid use disorder patient journey - Edison Group
Orexo soars after winning opioid drug appeal against Teva | Reuters
Actavis - Recent News & Activity
Actavis - Recent News & Activity
Teva Announces FDA Approval of First and Only Digital Inhaler with Built-In Sensors – ProAir® Digihaler™ | SnackSafely.com
History of the discovery, development, and FDA-approval of buprenorphine medications for the treatment of opioid use disorder - ScienceDirect
Teva Wins Patent Case Related to Orexo Opioid-Treatment Drug - Bloomberg
Type headline here
MRx Pipeline October 2023 by Magellan Rx Management - Issuu
Orexo Patent for Opioid Dependency Treatment Blocks Actavis' Generic
AL-SF-01122
The new Teva grows stronger in Norway
Teva Wins Patent Case Related to Orexo Opioid-Treatment Drug - Bloomberg
Type headline here
EX-99.1
Teva Wins Patent Case Related to Orexo Opioid-Treatment Drug - Bloomberg
Rebateable Labelers January 2021
Annual Report
Teva Wins Patent Case Related to Orexo Opioid-Treatment Drug - Bloomberg
MASTER] Mydayis Complaint (01776165).DOCX
Importance of personalized therapies | Deloitte Insights
Prescription Addiction: Big Pharma and the Opioid Epidemic
